Survival With Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era"
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Survival With Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data From 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
Eur Urol 2014 Oct 06;[EPub Ahead of Print], ND James, MR Spears, NW Clarke, DP Dearnaley, JS De Bono, J Gale, J Hetherington, PJ Hoskin, RJ Jones, R Laing, JF Lester, D McLaren, CC Parker, MK Parmar, AW Ritchie, JM Russell, RT Strebel, GN Thalmann, MD Mason, MR SydesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.